Long-term safety and tolerability of USl255 (qudexy™ xr; extended-release topiramate) in patients with refractory partial-onset seizures: Prevail ole

Authors
Category Primary study
JournalEpilepsy Currents
Year 2015
This article has no abstract
Epistemonikos ID: 9bd14f76355069908a27477f9fb68b0b97dca89e
First added on: Feb 07, 2025